Skip to main content

Table 4 Factors influencing the seroprevalence of anti-AMA1 antibodies

From: Sero-epidemiological evaluation of Plasmodium falciparum malaria in Senegal

 

Number (%)

OR (95% CI)

ORa (95% CI)

p value

Age group (year)

 <1

57 (39.1%)

1

1

 

 1–4

322 (32.2%)

0.74 (0.5–1.06)

0.82 (0.56–1.18)

0.28

 5–10

332 (46.1%)

1.34 (0.93–1.92)

1.18 (0.8–1.73)

0.43

Gender

 Female

355 (38.7%)

1

1

 

 Male

356 (37.5%)

0.95 (0.79–1.14)

0.97 (0.81–1.18)

0.82

Nutritionnel status

 Stunting

251 (37.97%)

0.99 (0.81–1.2)

0.94 (0.83–1.21)

0.62

 Underweight

182 (36.62)

0.92 (0.74–1.13)

0.97 (0.87–1.2)

0.79

 Wasting

62 (31.63%)

0.73 (0.53–0.99)

0.81 (0.57–1.15)

0.25

Anemia

 No

226 (43.88%)

1

1

 

 Yes

485 (35.93%)

0.72 (0.58–0.88)

0.72 (0.57–0.92)

0.005

Malaria parasite

 No

673 (37.98%)

1

1

 

 Yes

38 (40.86)

1.23 (0.74–1.72)

1.13 (0.74–1.72)

0.56

Residence area

 Keur Soce

310 (31.03%)

1

1

 

 Velingara

401 (46.30%)

1.92 (1.58–2.32)

1.85 (1.58–2.32)

<10−3